PetIQ, Inc. (PETQ)

Market Cap	530.27M
Revenue (ttm)	1.07B
Net Income (ttm)	12.78M
Shares Out	29.19M
EPS (ttm)	0.43
PE Ratio	41.91
Forward PE	21.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	228,665
Open	18.04
Previous Close	18.14
Day's Range	17.98 - 18.74
52-Week Range	8.75 - 22.98
Beta	1.76
Analysts	Strong Buy
Price Target	29.33 (+62.76%)
Earnings Date	Nov 7, 2023

About PETQ

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jul 21, 2017
• Employees: 1,076
• Stock Exchange: NASDAQ
• Ticker Symbol: PETQ

Financial Performance

In 2022, PetIQ's revenue was $921.51 million, a decrease of -1.18% compared to the previous year's $932.53 million. Losses were -$48.21 million, 201.9% more than in 2021.

Analyst Forecast

According to 3 analysts, the average rating for PETQ stock is "Strong Buy." The 12-month stock price forecast is $29.33, which is an increase of 62.76% from the latest price.

Price Target

$29.33

(62.76% upside)

Analyst Consensus: Strong Buy